Goldiam: consolidated PAT up 58% YoY to ₹49.4 Cr on B2B strength, but Origem rollout trails plan
PAT +57.53% YoY · revenue +42.11% · margins expanding
₹274 Cr
+42.11% YoY
₹49.4 Cr
+57.53% YoY
16.94%
+1.4pp YoY
₹4.38
Goldiam International's consolidated (primary) PAT rose 58% YoY to ₹49.40 Cr on revenue from operations of ₹274.00 Cr, up 42% YoY — a record Q2 on both counts, with no exceptional items on either side of the comparison so the growth is clean. NPM expanded 141 bps YoY to 16.94% and EBITDA margin (OPM) expanded 176 bps YoY to 25.24%, driven by the continued mix shift toward lab-grown diamond (LGD) jewellery, which held at 91.2% of export sales versus 90% a year ago. Sequentially, revenue fell 16% and PAT fell 33% from an unusually strong Q1 FY27 (₹326.03 Cr revenue, ₹73.97 Cr PAT); both margins also compressed QoQ (NPM -340 bps, OPM -333 bps). Management has flagged order-based revenue visibility running into Q2, so this reads as quarter-to-quarter order lumpiness in a B2B exporter rather than a demand reversal — YoY is the number that matters here.
Q2 FY-2027 vs prior quarters
Against the company's own February 2026 outlook, the B2B export engine is tracking ahead: segment (jewellery) revenue grew 43.7% YoY to ₹283.08 Cr, consistent with management's stated confidence in doubling the B2B business over 3-5 years and gaining wallet share as large US retailers consolidate vendors — a claim Executive Chairman Rashesh Bhansali repeated in today's press release, tying it directly to the >40% topline growth and the LGD mix. The B2C ORIGEM chain is a different story: management had guided to 24-26 stores by FY26-end plus 50 more in H1 FY27, implying roughly 74-76 stores by now; the company instead had 29 operational ORIGEM stores as of November 7, 2026, with only three added in the September quarter (27th-29th stores, per company announcements). MD Anmol Bhansali's press-release framing that ORIGEM is 'expanding as planned' does not square with that numeric target, so the store-rollout guidance reads as missed even as the B2B segment outperforms. No brokerage-specific consensus estimate for this quarter could be located; the one external FY27 reference found (sharpely.in) pegs full-year street PAT growth at 15-20%, a bar H1 FY27's 90% consolidated PAT growth has already cleared.
The stock went into the print at ₹316.65, down 0.1% over the past month of trading.
Management anticipates a record financial year (FY26) for revenue, EBITDA, and PAT, driven by strong performance in its B2B lab-grown diamond jewelry exports and aggressive expansion of its B2C Origem brand. For B2C, Goldiam plans to expand to 24-26 stores by FY26 end and an additional 50 stores in H1 FY27, targeting s
— This quarter: missed
Standalone (parent-only) numbers grew faster than consolidated — PAT +93% YoY to ₹25.43 Cr on revenue +56% YoY to ₹163.26 Cr — a gap wide enough to flag: it suggests the overseas subsidiaries (Goldiam USA, Diagold Designs, Eco-Friendly Diamond LLP) grew slower than the parent this quarter. Corporate actions alongside the results: a 1st interim FY27 dividend of ₹2/share (100%, ₹30.11 Cr total) and a bonus share issue that lifted paid-up capital from ₹22.58 Cr to ₹30.11 Cr during the quarter, which is why diluted EPS (₹2.96, +3.9% YoY) lagged basic EPS (₹4.38) and PAT growth so sharply — a per-share dilution effect, not an earnings-quality issue. Order book stood at ₹225 Cr as of September 30, 2026, and cash & equivalents (including investments) at ₹457.83 Cr.
W1
ORIGEM store count trajectory — management's own H1 FY27 target implied ~74-76 stores; only 29 are open, so whether the pace accelerates in H2 FY27 is a direct guidance checkpoint
W2
Whether Q3 FY27 reverts toward Q1's ₹326 Cr/₹74 Cr run-rate or confirms Q2's lower base, given management's statement that an export order's execution (originally scheduled by Aug 30, 2026) was driving Q1-Q2 revenue visibility
W3
EBITDA margin band — management/analyst tracking range cited at 18-23%; Q2's 25.24% is above that band and its direction next quarter will show if the LGD-mix-driven expansion holds
No exceptional items either period; tax = current+deferred tax. Consolidated PAT uses the pre-OCI 'Profit for the Period' row (matches press release's ₹494mn), not the post-OCI/minority 'Net Profit' row. One unreviewed subsidiary (revenue ₹228.38 Cr for the quarter before consolidation adjustments) flagged by auditors but review conclusion unmodified. Diluted EPS (₹2.96) is well below basic EPS (₹4.38) and grew only 3.9% YoY vs PAT +58% because paid-up capital rose from ₹22.58 Cr to ₹30.11 Cr on a bonus issue during the quarter. Standalone PAT/revenue grew materially faster YoY (+93%/+56%) than consolidated (+58%/+42%) — a >3% divergence pointing to softer growth in the overseas (US) subsidiaries within the group number.